Puma Biotechnology, Inc. (NASDAQ: PBYI), a biopharmaceutical company, announced that on June 6, 2024, the Compensation ...

Patients with resectable stage 3 melanoma should talk about pretreatment therapy with their cancer care teams, an expert said ...

A study finds 1 year of avelumab treatment improves distant disease free and overall survival rates in patients with early ...

Discover how Novavax Inc's innovative vaccine composition targets C. difficile infections with a multivalent immunogenic polypeptide. Learn about the patent's detailed amino acid sequences, ...

Armaghani, MD, highlights two key presentations. First, a retrospective study on adjuvant endocrine therapy in ER-low breast ...

Two courses of neoadjuvant ipilimumab/nivolumab highly improve event free survival (EFS) in patients with macroscopic stage 3 ...

Neoadjuvant ipilimumab plus nivolumab followed by surgery results in longer event-free survival than surgery followed by ...

As they explained in the Journal of Surgical Case Reports, the patient had no noteworthy medical history nor had she received ...

NRG Oncology recently reported the results from the radiotherapy randomization, which was the second step of their NRG-RTOG ...

AgZen, a Boston-based startup backed by venture firm Material Impact, has fielded a bolt-on system that works on any sprayer regardless of brand or configuration.

The data presented at ASCO's annual meeting are promising, experts said, but will need longer follow-up to prove there is a benefit for patients.

At the ASCO conference, investigators highlighted the potential of Moderna’s cancer vaccine combination based on Phase II ...